With a view to achieve better integration between the Health policies and the industrial policies in the Pharmaceutical sector, an inter-ministerial Standing Committee would be constituted in the Ministry of Industry Department of Chemicals and Petrochemicals with Secretary, Ministry of Health and officials of the other Departments and agencies concerned as members. In the first instance, the Committee would oversee the implementation of the new measures and other related decisions such as revision of the National Formulary, strengthening of the institutional and statutory arrangements for enforcing quality control, dissemination of information regarding safety and efficacy of drugs to medical and paramedical personnel, centralization of drug registration, rationalization of formulations and monitoring of adverse reactions.

• Introductory
• Part II – Objectives
• Part III – Rational Use of Drugs
• Part IV-Quality Control
• Part V – Pricing
• Part VI – Licensing
• Part VII – Duty Rationalization
• Part VIII – Co-Ordination Between Health and Industry Ministries
• Part IX – Review
• Annexure I(Refer to Paragraph 6.1)
• Annexure – II (Refer to Paragraph 6.3)
• Annexure – III (Refer to Paragraph 6.8)